drugset / Trial / NCT00276146
Dipyridamole/Magnesium To Improve Sickle Cell Hydration
RandomizedCrossoverDouble-blind
Summary
The purpose of this study is to determine the benefits as well as side effects of giving drugs called dipyridamole and magnesium to patients with sickle cell anemia (SCA).
Timeline
- Start
- 2005-05
- Primary completion
- —
- Completion
- —
Outcome
Outcome not reported
Stopped (Enrollment): “The NHLBI BSMB recommended closure due to poor enrollment.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dipyridamole | Other / unclassified | — | Oral |
| Subject | Magnesium | Other / unclassified | — | Oral |